Accurate genotyping of hepatitis C virus through nucleotide sequencing and identification of new HCV subtypes in China population

Clinical Microbiology and Infection

Volumn 21, Issue 9, 2015, Pages 874.e9-874.e21

  Tong, Y Q ^a,b   Liu, B ^c   Liu, H ^b,d   Zheng, H Y ^b   Gu, J ^a   Song, E J ^e   Song, C ^e   Li, Y ^a,b  

^a Department of Clinical Laboratory ^*  (China)

^b RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^c WUHAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^d SECOND MILITARY MEDICAL UNIVERSITY   (China)

^e PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Genotype; Hepatitis C virus; Ns5b; Sequencing; Subtype

Indexed keywords

NONSTRUCTURAL PROTEIN 5B; VIRUS DNA; VIRUS RNA; NS-5 PROTEIN, HEPATITIS C VIRUS; PRIMER DNA; VIRUS PROTEIN;

ADULT; AGED; ARTICLE; CHINA; DATA BASE; FEMALE; GEL ELECTROPHORESIS; GENE AMPLIFICATION; GENOTYPE; GENOTYPING TECHNIQUE; HEPATITIS C VIRUS; HEPATITIS C VIRUS SUBTYPE 1B; HEPATITIS C VIRUS SUBTYPE 2A; HEPATITIS C VIRUS SUBTYPE 3B; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN; CLASSIFICATION; DNA SEQUENCE; EVALUATION STUDY; GENETICS; HEPACIVIRUS; HEPATITIS C; ISOLATION AND PURIFICATION; MIDDLE AGED; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY; YOUNG ADULT;

HEPATITIS C VIRUS;

ADULT; AGED; CHINA; DNA PRIMERS; FEMALE; GENOTYPE; GENOTYPING TECHNIQUES; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; VIRAL NONSTRUCTURAL PROTEINS; YOUNG ADULT;

EID: 84940614829     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2015.05.034     Document Type: Article

References (49)

1. Thomas D.L. Global control of hepatitis c: where challenge meets opportunity. Nat Med 2013, 19:850-858.
2. Mohd Hanafiah K., Groeger J., Flaxman A.D., Wiersma S.T. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013, 57:1333-1342.
3. Lavanchy D. Evolving epidemiology of hepatitis c virus. Clin Microbiol Infect 2011, 17:107-115.
4. Venook A.P., Papandreou C., Furuse J., de Guevara L.L. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 2010, 15(Suppl.4):5-13.
5. Negro F., Alberti A. The global health burden of hepatitis C virus infection. Liver Int 2011, 31(Suppl.2):1-3.
6. Simmonds P. Viral heterogeneity of the hepatitis C virus. JHepatol 1999, 31(Suppl.1):54-60.
7. Irshad M., Ansari M.A., Singh A., Nag P., Raghvendra L., Singh S., et al. HCV-genotypes: a review on their origin, global status, assay system, pathogenecity and response to treatment. Hepato-gastroenterology 2010, 57:1529-1538.
8. Smith D.B., Simmonds P. Hepatitis C virus: types, subtypes, and beyond. Methods Mol Med 1999, 19:133-146.
9. Kuiken C., Yusim K., Boykin L., Richardson R. The Los Alamos hepatitis C sequence database. Bioinformatics 2005, 21:379-384.
10. Kuiken C., Hraber P., Thurmond J., Yusim K. The hepatitis C sequence database in Los Alamos. Nucleic Acids Res 2008, 36:D512-D516.
11. Dusheiko G., Simmonds P. Sequence variability of hepatitis C virus and its clinical relevance. JViral Hepat 1994, 1:3-15.
12. Mondelli M.U., Silini E. Clinical significance of hepatitis C virus genotypes. JHepatol 1999, 31(Suppl.1):65-70.
13. Croagh C.M., Lubel J. Advances in the management of hepatitis C. Intern Med J 2013, 43:1265-1271.
14. Nelson P.K., Mathers B.M., Cowie B., Hagan H., Des Jarlais D., Horyniak D., et al. Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet 2011, 378:571-583.
15. Grebely J., Dore G.J. What is killing people with hepatitis C virus infection?. Semin Liver Dis 2011, 31:331-339.
16. Hajarizadeh B., Grebely J., Dore G.J. Epidemiology and natural history of HCV infection. Nat Rev Gastroenterol Hepatol 2013, 10:553-562.
17. Nguyen L.H., Nguyen M.H. Systematic review: Asian patients with chronic hepatitis C infection. Aliment Pharmacol Ther 2013, 37:921-936.
18. Gryadunov D., Nicot F., Dubois M., Mikhailovich V., Zasedatelev A., Izopet J. Hepatitis C virus genotyping using an oligonucleotide microarray based on the NS5B sequence. JClin Microbiol 2010, 48:3910-3917.
19. Larrat S., Poveda J.D., Coudret C., Fusillier K., Magnat N., Signori-Schmuck A., et al. Sequencing assays for failed genotyping with the versant hepatitis C virus genotype assay (lipa), version 2.0. JClin Microbiol 2013, 51:2815-2821.
20. Sam S.S., Steinmetz H.B., Tsongalis G.J., Tafe L.J., Lefferts J.A. Validation of a solid-phase electrochemical array for genotyping hepatitis C virus. Exp Mol Pathol 2013, 95:18-22.
21. Nakao T., Enomoto N., Takada N., Takada A., Date T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. JGen Virol 1991, 72(Pt 9):2105-2112.
22. Weck K. Molecular methods of hepatitis C genotyping. Exp Rev Mol Diagn 2005, 5:507-520.
23. Smith D.B., Bukh J., Kuiken C., Muerhoff A.S., Rice C.M., Stapleton J.T., et al. Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource. Hepatology 2014, 59:318-327.
24. Laperche S., Lunel F., Izopet J., Alain S., Dény P., Duverlie G., et al. Comparison of hepatitis C virus NS5B and 5' noncoding gene sequencing methods in a multicenter study. JClin Microbiol 2005, 43:733-739.
25. Nakano T., Lau G.M., Sugiyama M., Mizokami M. An updated analysis of hepatitis C virus genotypes and subtypes based on the complete coding region. Liver Int 2012, 32:339-345.
26. Golemba M.D., Culasso A.C., Villamil F.G., Bare P., Gadano A., Ridruejo E., et al. Hepatitis C virus diversification in Argentina: comparative analysis between the large city of Buenos Aires and the small rural town of O'Brien. PloS One 2013, 8:e84007.
27. Nakatani S.M., Santos C.A., Riediger I.N., Krieger M.A., Duarte C.A., do Carmo Debur M., et al. Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of Brazilian patients with chronic hepatitis C. Virol J 2011, 8:459.
28. Elsadek Fakhr A., Pourkarim M.R., Maes P., Atta A.H., Marei A., Azab M., et al. Hepatitis C virus NS5B sequence-based genotyping analysis of patients from the Sharkia governorate. Egypt Hepat Monthly 2013, 13:e12706.
29. Simmonds P., Mellor J., Sakuldamrongpanich T., Nuchaprayoon C., Tanprasert S., Holmes E.C., et al. Evolutionary analysis of variants of hepatitis C virus found in South-East Asia: comparison with classifications based upon sequence similarity. JGen Virol 1996, 77(Pt 12):3013-3024.
30. Cantaloube J.F., Laperche S., Gallian P., Bouchardeau F., de Lamballerie X., de Micco P. Analysis of the 5' noncoding region versus the NS5B region in genotyping hepatitis C virus isolates from blood donors in France. JClin Microbiol 2006, 44:2051-2056.
31. Oprişan G., Szmal C., Dinu S., Oprişoreanu A.M., Thiers V., Panait M., et al. Comparative methods for genotyping hepatitis C virus isolates from Romania. Roum Arch Microbiol Immunol 2009, 68:151-157.
32. Koletzki D., Dumont S., Vermeiren H., Fevery B., De Smet P., Stuyver L.J. Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay. Clin Chem Lab Med 2010, 48:1095-1102.
33. Murphy D.G., Willems B., Deschenes M., Hilzenrat N., Mousseau R., Sabbah S. Use of sequence analysis of the NS5B region for routine genotyping of hepatitis C virus with reference to c/e1 and 5' untranslated region sequences. JClin Microbiol 2007, 45:1102-1112.
34. Jacka B., Lamoury F., Simmonds P., Dore G.J., Grebely J., Applegate T. Sequencing of the hepatitis C virus: a systematic review. PloS One 2013, 8:e67073.
35. Gower E., Estes C., Blach S., Razavi-Shearer K., Razavi H. Global epidemiology and genotype distribution of the hepatitis C virus infection. JHepatol 2014, 61:S45-S57.
36. Messina J.P., Humphreys I., Flaxman A., Brown A., Cooke G.S., Pybus O.G., et al. Global distribution and prevalence of hepatitis C virus genotypes. Hepatology 2015, 61:77-87.
37. Zein N.N. Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 2000, 13:223-235.
38. Tanaka H., Tsukuma H., Yamano H., Okubo Y., Inoue A., Kasahara A., et al. Hepatitis C virus 1b(ii) infection and development of chronic hepatitis, liver cirrhosis and hepatocellular carcinoma: a case-control study in Japan. JEpidemiol 1998, 8:244-249.
39. Sugo H., Balderson G.A., Crawford D.H., Fawcett J., Lynch S.V., Strong R.W., et al. The influence of viral genotypes and rejection episodes on the recurrence of hepatitis C after liver transplantation. Surg Today 2003, 33:421-425.
40. Murase J., Kubo S., Nishiguchi S., Hirohashi K., Shuto T., Ikebe T., et al. Correlation of clinicopathologic features of resected hepatocellular carcinoma with hepatitis C virus genotype. Jpn J Cancer Res 1999, 90:1293-1300.
41. Sobesky R., Feray C., Rimlinger F., Derian N., Dos Santos A., Roque-Afonso A.M., et al. Distinct hepatitis C virus core and f protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection. Hepatology 2007, 46:1704-1712.
42. + patients. Hepatol Res 2005, 32:227-234.
43. Jiang J., Wu X., Tang H., Luo G. Apolipoprotein E mediates attachment of clinical hepatitis C virus to hepatocytes by binding to cell surface heparan sulfate proteoglycan receptors. PloS One 2013, 8:e67982.
44. Petruzziello A., Coppola N., Loquercio G., Marigliano S., Giordano M., Azzaro R., et al. Distribution pattern of hepatitis C virus genotypes and correlation with viral load and risk factors in chronic positive patients. Intervirology 2014, 57:311-318.
45. Thong V.D., Akkarathamrongsin S., Poovorawan K., Tangkijvanich P., Poovorawan Y. Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication. World J Gastroenterol 2014, 20:2927-2940.
46. Kageyama S., Agdamag D.M., Alesna E.T., Leaño P.S., Heredia A.M., Abellanosa-Tac-An I.P., et al. Anatural inter-genotypic (2b/1b) recombinant of hepatitis C virus in the Philippines. JMed Virol 2006, 78:1423-1428.
47. Moreno M.P., Casane D., Lopez L., Cristina J. Evidence of recombination in quasispecies populations of a hepatitis C virus patient undergoing anti-viral therapy. Virol J 2006, 3:87.
48. Legrand-Abravanel F., Claudinon J., Nicot F., Dubois M., Chapuy-Regaud S., Sandres-Saune K., et al. New natural intergenotypic (2/5) recombinant of hepatitis C virus. JVirol 2007, 81:4357-4362.
49. Sentandreu V., Jiménez-Hernández N., Torres-Puente M., Bracho M.A., Valero A., Gosalbes M.J., et al. Evidence of recombination in intrapatient populations of hepatitis C virus. PloS One 2008, 3:e3239.